CFO for Lion Biotechnologies Will Leave the Company

Lion Biotechnologies (NASDAQ:LBIO) announced their CFO Gregory Schiffman will leave the company due to personal reasons.
As quoted in the press release:

Mr. Schiffman will remain in his current role until June 22, 2017. A search for a new CFO is underway through a recruitment agency.
Lion’s accounting, tax and financial reporting functions will continue to be provided by Franco Valle, current Principal Accounting Officer and Controller, and Lion’s other in-house accounting personnel. Mr. Valle joined Lion Biotechnologies in July 2016 and has been responsible for such functions since then.
“We would like to thank Greg for his contributions and the dedication he brought to Lion, and wish him well in his future endeavors,” said Maria Fardis, PhD, MBA, Chief Executive Officer of Lion Biotechnologies.

Click here to read the full press release.

Source: www.marketwired.com